Effects of 12 weeks of aerobic training on autonomic modulation, mucociliary clearance, and aerobic parameters in patients with COPD

Carregando...
Imagem de Miniatura
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2015
Editora
DOVE MEDICAL PRESS LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
LEITE, Marceli Rocha
RAMOS, Ercy Mara Cipulo
KALVA-FILHO, Carlos Augusto
FREIRE, Ana Paula Coelho Figueira
SILVA, Bruna Spolador de Alencar
NICOLINO, Juliana
PAPOTI, Marcelo
VANDERLEI, Luiz Carlos Marques
RAMOS, Dionei
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, v.10, p.2549-2557, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Patients with chronic obstructive pulmonary disease (COPD) exhibit aerobic function, autonomic nervous system, and mucociliary clearance alterations. These parameters can be attenuated by aerobic training, which can be applied with continuous or interval efforts. However, the possible effects of aerobic training, using progressively both continuous and interval sessions (ie, linear periodization), require further investigation. Aim: To analyze the effects of 12-week aerobic training using continuous and interval sessions on autonomic modulation, mucociliary clearance, and aerobic function in patients with COPD. Methods: Sixteen patients with COPD were divided into an aerobic (continuous and interval) training group (AT) (n= 10) and a control group (CG) (n= 6). An incremental test (initial speed of 2.0 km.h(-1), constant slope of 3%, and increments of 0.5 km.h(-1) every 2 minutes) was performed. The training group underwent training for 4 weeks at 60% of the peak velocity reached in the incremental test (vVO(2peak)) (50 minutes of continuous effort), followed by 4 weeks of sessions at 75% of vVO(2peak) (30 minutes of continuous effort), and 4 weeks of interval training (5x3-minute effort at vVO(2peak), separated by 1 minute of passive recovery). Intensities were adjusted through an incremental test performed at the end of each period. Results: The AT presented an increase in the high frequency index (ms(2)) (P= 0.04), peak oxygen uptake (VO2peak) (P= 0.01), vVO(2peak) (P= 0.04), and anaerobic threshold (P= 0.02). No significant changes were observed in the CG (P > 0.21) group. Neither of the groups presented changes in mucociliary clearance after 12 weeks (AT: P= 0.94 and CG: P= 0.69). Conclusion: Twelve weeks of aerobic training (continuous and interval sessions) positively influenced the autonomic modulation and aerobic parameters in patients with COPD. However, mucociliary clearance was not affected by aerobic training.
Palavras-chave
COPD, exercise, aerobic treatment, mucociliary clearance
Referências
  1. Afonso JL, 2013, REV PORT PNEUMOL, V19, P211, DOI 10.1016/j.rppneu.2013.03.002
  2. ANDERSEN I, 1974, ARCH ENVIRON HEALTH, V29, P290, DOI 10.1080/00039896.1974.10666589
  3. Andrianopoulos V, 2014, CLIN CHEST MED, V35, P313, DOI 10.1016/j.ccm.2014.02.013
  4. Beauchamp MK, 2010, THORAX, V65, P157, DOI 10.1136/thx.2009.123000
  5. Bertuzzi R. C. M., 2009, REV BRAS CIN DES HUM, V11, P226
  6. Bhowmik A, 2009, RESP MED, V103, P496, DOI 10.1016/j.rmed.2008.10.014
  7. Borghi-Silva A, 2006, BRAZ J MED BIOL RES, V39, P465, DOI 10.1590/S0100-879X2006000400006
  8. Borghi-Silva A, 2009, RESP MED, V103, P1503, DOI 10.1016/j.rmed.2009.04.015
  9. Bragada JA, 2010, J SPORT SCI MED, V9, P439
  10. Camillo CA, 2011, RESP MED, V105, P1054, DOI 10.1016/j.rmed.2011.01.014
  11. Camm AJ, 1996, CIRCULATION, V93, P1043
  12. Caputo F, 2009, REV BRAS CIN DES HUM, V11, P94
  13. Ramos EMC, 2011, RESPIROLOGY, V16, P849, DOI 10.1111/j.1440-1843.2011.01985.x
  14. Duarte Andrezza Araújo de Oliveira, 2007, J. bras. pneumol., V33, P527, DOI 10.1590/S1806-37132007000500007
  15. Esteve-Lanao J, 2007, J STRENGTH COND RES, V21, P943, DOI 10.1519/00124278-200708000-00048
  16. Ganesan S, 2013, CURR PULMONOL REP, V2, P145, DOI 10.1007/s13665-013-0052-2
  17. Global Initiative for Chronic Obstructive Lung Disease (GOLD), GLOB STRAT DIAGN MAN
  18. Godoy MF, 2005, ARQ CIENC SAUDE, V12, P167
  19. Hsieh MJ, 2007, RESPIROLOGY, V12, P381, DOI 10.1111/j.1400-1843.2007.01077.x
  20. Kendrick K R, 2000, J Emerg Nurs, V26, P216
  21. KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839
  22. Leite MR, 2015, RESPIROLOGY, V20, P273, DOI 10.1111/resp.12424
  23. Lohman T, 1988, ANTHROPOMETRIC STAND
  24. Vanderlei LCM, 2009, REV BRAS CIR CARDIOV, V24, P205, DOI 10.1590/S0102-76382009000200018
  25. Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
  26. Moreno IL, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-2
  27. Munoz I, 2014, INT J SPORT PHYSIOL, V9, P265, DOI [10.1123/IJSPP.2012-0350, 10.1123/ijspp.2012-0350]
  28. Nakagawa NK, 2005, CHEST, V128, P2772, DOI 10.1378/chest.128.4.2772
  29. Nicola ML, 2014, CHEST, V145, P998, DOI 10.1378/chest.13-1355
  30. Reis LFF, 2013, EUR J PHYS REHAB MED, V49, P491
  31. SALAH B, 1988, EUR RESPIR J, V1, P852
  32. SALH W, 1989, THORAX, V44, P1006, DOI 10.1136/thx.44.12.1006
  33. Salzano F A, 2000, Acta Otorhinolaryngol Ital, V20, P171
  34. SMALDONE GC, 1993, CHEST, V103, P1390, DOI 10.1378/chest.103.5.1390
  35. Spruit MA, 2002, EUR RESPIR J, V19, P1072, DOI 10.1183/09031936.02.00287102
  36. Stellingwerff T, 2012, INT J SPORT NUTR EXE, V22, P392, DOI 10.1123/ijsnem.22.5.392
  37. SUE DY, 1988, CHEST, V94, P931, DOI 10.1378/chest.94.5.931
  38. Tarvainen M P, 2008, 4th European Conference of the International Federation for Medical and Biological Engineering - ECIFMBE 2008, P1022
  39. van Helvoort HA, 2011, ARCH PHYS MED REHAB, V92, P111, DOI 10.1016/j.apmr.2010.08.012
  40. Vanderlei LCM, 2008, BRAZ J MED BIOL RES, V41, P854, DOI 10.1590/S0100-879X2008005000039
  41. Wadell K, 2013, COPD, V10, P425, DOI 10.3109/15412555.2012.758696
  42. WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236
  43. WOLFF RK, 1977, J APPL PHYSIOL, V43, P46